Novartis (SWX:NOVN) has recorded its 29th consecutive annual dividend increase, extending a nearly three decade payout track ...

This report provides an in-depth analysis of the Cell and Gene Therapy industry, highlighting key company revenues, regulatory approvals, and market trends. It has been compiled by Towards Healthcare, ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

More than two years after its approval, only about 60 patients across the U.S., Middle East, and Europe have been treated ...

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

Gene therapy is a medical treatment that works by changing or fixing a person's genes to treat or prevent disease ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...

The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...

Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...